PT2.14.05 Redefining Clinical Outcomes for Peritoneal Mesothelioma (PeM) in the Era of Immunotherapy
Back to course
Asset Subtitle
Yamato Takabe
Meta Tag
Speaker Yamato Takabe
Topic Mesothelioma, Thymoma, and Other Thoracic Tumors
Powered By